Would An Independent Analysis Of US FDA's Pandemic Response Find Transformative Effect?

Group of outside experts could help the agency determine the pandemic-inspired practices and regulatory changes to keep, former commissioner von Eschenbach says.

Screenshot from FDLI Annual Conference of former commissioners' discussion
Former FDA commissioners Andrew von Eschenbach, top left, Robert Califf, bottom left, and Mark McClellan, bottom right, discuss how the pandemic changed the agency with FDLI president and CEO Amy Comstock Rick. • Source: FDLI annual conference screenshot

More from Leadership

More from HBW Insight